Cargando…
Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100)
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315265/ http://dx.doi.org/10.1186/1479-5876-13-S1-O11 |
| _version_ | 1782355447792009216 |
|---|---|
| author | Daud, Adil Algazi, Alain Ashworth, Michelle Buljan, Michael Takamura, Kathryn Toshimi Diep, Tu Pierce, Robert H Bhatia, Shailender |
| author_facet | Daud, Adil Algazi, Alain Ashworth, Michelle Buljan, Michael Takamura, Kathryn Toshimi Diep, Tu Pierce, Robert H Bhatia, Shailender |
| author_sort | Daud, Adil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4315265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43152652015-02-12 Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100) Daud, Adil Algazi, Alain Ashworth, Michelle Buljan, Michael Takamura, Kathryn Toshimi Diep, Tu Pierce, Robert H Bhatia, Shailender J Transl Med Oral Presentation BioMed Central 2015-01-15 /pmc/articles/PMC4315265/ http://dx.doi.org/10.1186/1479-5876-13-S1-O11 Text en Copyright © 2015 Daud et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Daud, Adil Algazi, Alain Ashworth, Michelle Buljan, Michael Takamura, Kathryn Toshimi Diep, Tu Pierce, Robert H Bhatia, Shailender Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100) |
| title | Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100) |
| title_full | Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100) |
| title_fullStr | Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100) |
| title_full_unstemmed | Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100) |
| title_short | Intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (OMS-I100) |
| title_sort | intratumoral electroporation of plasmid interleukin-12: efficacy and biomarker analyses from a phase 2 study in melanoma (oms-i100) |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315265/ http://dx.doi.org/10.1186/1479-5876-13-S1-O11 |
| work_keys_str_mv | AT daudadil intratumoralelectroporationofplasmidinterleukin12efficacyandbiomarkeranalysesfromaphase2studyinmelanomaomsi100 AT algazialain intratumoralelectroporationofplasmidinterleukin12efficacyandbiomarkeranalysesfromaphase2studyinmelanomaomsi100 AT ashworthmichelle intratumoralelectroporationofplasmidinterleukin12efficacyandbiomarkeranalysesfromaphase2studyinmelanomaomsi100 AT buljanmichael intratumoralelectroporationofplasmidinterleukin12efficacyandbiomarkeranalysesfromaphase2studyinmelanomaomsi100 AT takamurakathryntoshimi intratumoralelectroporationofplasmidinterleukin12efficacyandbiomarkeranalysesfromaphase2studyinmelanomaomsi100 AT dieptu intratumoralelectroporationofplasmidinterleukin12efficacyandbiomarkeranalysesfromaphase2studyinmelanomaomsi100 AT pierceroberth intratumoralelectroporationofplasmidinterleukin12efficacyandbiomarkeranalysesfromaphase2studyinmelanomaomsi100 AT bhatiashailender intratumoralelectroporationofplasmidinterleukin12efficacyandbiomarkeranalysesfromaphase2studyinmelanomaomsi100 |